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follow up clinics notes and via phone calls. Data interpreted by using
logistic regression analysis.
Results: 176 patients were studied. Mean age 54.0 years, of which
86.9% were male. 11 patients (6.3%) died within 30 days after PPCI. No
significant difference in outcome for gender and age groups. Prolonged
door in door out (DIDO) at primary hospital showed higher mortality
rate (b30 minutes: 4.8% p=0.549, 30-60min: 5.3% p=0.708, N60min:
11.1% p=0.165). Longer door to device (DTD) duration is associated
with higher mortality rate in both PCI-capable Hospital (b90minutes:
4.8% vs N90min: 12.5%, p=0.342) and non-PCI-capable hospitals
(b120min: 3.6% vs N120min: 9.1% p=0.359). Systolic blood press-
ure(BP) is significant factor affecting patients' outcome (Odd Ratio
(OR)=0.959 (0.935-0.983), p=0.001). Systolic BP b 100mmHg (OR
4.339 (1.295-14.543), p=0.045), and diastolic BP b 60mmHg (OR=
4.339 (1.295-14.543), p=0.045) are associated with high mortality.
Patients presented with Killip I (OR 0.202 (0.062-6.59), p=0.008) had
favorable outcome while patients presented with Killip IV (OR 6.151
(2.056-18.40), p=0.04) had poor outcome in this study.
Conclusion: PPCI for acute STEMI 30 days mortality rate is 6.3%.
Outcome of patients with Killip IV remained poor despite immediate
intervention. Blood pressure is an important factor predicting patients'
outcome. Shorter transfer time associated with better outcome but not
statistically significant. As STEMI network in this region is expanding, a
more comprehensive outcomes study will be obtained with longer
study period and bigger sample size.
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Background: Despite the evolution of interventional techniques
and operator experience, percutaneous revascularization of complex
coronary lesions especially calcified lesions remains challenging because
of lower procedural success and higher restenosis rates. Limited data are
available on the effect of rotational atherectomy (RA) plus stenting in
the treatment of complex calcified lesions of coronary artery disease.
Objective: This study is aimed to investigate the characteristics,
short and long term outcomes in patients undergoing RA.
Materials Methods: A database searchwas performed from the year
2008 to 2015 in the National Heart Institute KL. A total of 22,434 patients
who underwent PCIs were enrolled in 2 groups, RA group (408) and non-
RA group (22,026). The Chi Square test and Kaplan Meier analysis were
used.
Results:Male patients (82.6%) and elderly population (63.6%) were
predominant in the study. The RA group had more co-morbidities such
as diabetes on insulin (36%) and chronic kidney disease (58%).The
lesions in the RA group were more complex with higher Type C lesions
(75.6%) and longer (more than 20mm) (20.5%) compared to those in
the non-RA group. The procedural success rates were higher in the RA
group (98.3%) than in the non-RA group, though the difference was not
statistically significant (p=0.08). In terms of in-hospital outcome, there
was less peri-procedural MI (0.5%) and mortality (1.0%) in the non-RA
group compared to the RA group, whichwas statistically significant (Pb
0.001). The was significantly less incidence stent thrombosis in the RA
group compared to the non-RA group (pb 0.001). Compared to RA
group (90.7%), non RA group (97.1%) had higher rates of 1-year survival
in Kaplan-Meier survival graph (pb0.001).
Conclusion: Despite the complexity of lesions and increased co-
morbidities of patients in the RA group, the short and long term
outcomes are acceptable. This may be explained by better vessel
preparation and stent expansion following rotational atherectomy.
doi:10.1016/j.ijcard.2017.09.094
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Background: Primary percutaneous coronary intervention (PCI)
has been deemed to be superior to thrombolytic therapy in a large
number of clinical trials. This is the basis of formation of ST-elevation
myocardial infarction (STEMI) networks around the world. STEMI
networks are however frequently subjected to economical evaluation.
Objective: We sought to compare the outcomes between patients
with acute STEMI who were thrombolysed at the spoke hospital versus
patients who were transferred to our hospital (hub) for primary PCI.
Materials & Methods: A STEMI network was initiated on the 1st of
July 2015 between our hospital and a tertiary non-PCI-capable hospital.
The network is however active only during office hours (8.00 am to 5.00
pm). Our study included all patients presenting to the spoke hospital
with acute STEMI, who were either thrombolysed at the spoke hospital
or transferred to our hospital for primary PCI, from 1st of July 2015 to
31st of December 2015.
Results: Our study enrolled 70 patients of which 67 (95.7%) were
males and mean age was 55 years old. Forty-four patients were
thrombolysed while 26 were transferred for primary PCI. Majority of
patients were in Killip class I (64.3%). The median first medical contact
(FMC) to needle time was 50 minutes. The median door-in-door-out
(DIDO) time was 78 minutes and the median FMC to PCI time was 158
minutes. The 30-day mortality was 9% for patients who were
thrombolysed and 3.8% for patients who underwent primary PCI. The
median length of hospital stay was 5 days for patients who were
thrombolysed and 4 days for patients who underwent primary PCI.
Conclusions: Our study revealed that patients with acute STEMI
who underwent primary PCI at our hospital (hub) had lower 30-day
mortality rates and shorter length of hospital stay compared to patients
whowere thrombolysed at the spoke hospital; although the DIDO, FMC
to needle and FMC to PCI times were not ideal. We believe that the
results of our study serve as a good reason for creation of more STEMI
networks in the country although additional studies are needed to
assess the overall cost-effectiveness of the STEMI network.
doi:10.1016/j.ijcard.2017.09.095
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Background: Primary percutaneous coronary intervention (PCI)
is the preferred reperfusion strategy in patients with ST-segment
elevation myocardial infarction (STEMI). However, timely PCI cannot
be offered to many patients.
Objective: The purpose of this study was to compare the 30-day
clinical outcome of primary PCI strategy and fibrinolysis followed by
coronary angiography strategy in STEMI patients.
Methods: This was a prospective, observational, single center study.
All patients admitted for STEMI from 1 January 2016 to 30 November
2016 were screened for the study. Patients were divided into 2
reperfusion strategies: primary PCI or fibrinolysis followed by coronary
angiography. Primary outcome was composite of all-cause mortality at
30 days.
Results: A total of 178 patients were identified: 33 (18.5%)
underwent primary PCI and 145 (81.5%) underwent fibrinolysis first.
The median door-to-balloon time in the primary PCI group was 161.0
minutes (IQR 84.5). The median time from fibrinolysis-to-arrival at
catheterization lab was 1738 minutes (IQR 901). The median total
ischaemic time was 369 min (IQR 524) and 210 (IQR 247) for the
primary PCI and fibrinolysis first group respectively (p=0.002). Kaplan-
Meier survival analysis for 30-day all-cause mortality was 24.2% vs 9.7%
respectively in primary PCI and fibrinolysis group (p=0.018). Multivar-
iate Linear Regression showed that Killip Class and LVEF were
independent predictors of 30-day all-cause mortality. Reperfusion
strategy was not associated with 30-day all-cause mortality (p=0.216).
Conclusions: The clinical outcome of primary PCI strategy in
STEMI is not better than fibrinolysis followed by coronary angiogra-
phy strategy when timely PCI cannot be performed.
doi:10.1016/j.ijcard.2017.09.096
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Background: Trans-coronary ablation of septal hypertrophy
(TASH) has been shown to reduce outflow obstruction and symptom
relief in the short and intermediate period. We aimed to assess the
short and long term efficacy and safety in a single center experience.
Objectives: The aim is to assess the long-term efficacy and safety
of TASH in a single center experience.
Materials & Methods: There were 61 patients analyzed with
symptomatic hypertrophic obstructive cardiomyopathy (HOCM) that
underwent TASH procedure between 2005- 2017. All patient had serial
echocardiography prior to procedure and subsequent follow-up. Proce-
dural success was defined as improvement in patient symptoms and
reduction of the left ventricular outflow tract pressure gradient by at
least 50% on echocardiography
Results: The mean age of patients in our study is 49.4 ± 11.4
years. The majority of patients were male (72.7%).
The mean duration of follow-upwas 3.6 ± 2.4 years. The number of
septal branches ablatedwere 2.0±1.0 and themean alcohol used 3.1±
1.8 ml. LVOT gradient reduction bymore than 50% was achieved in 91%
of patients immediately post TASH,withmean LVOT gradient reduction
from 83 ± 37 mmHg to 42 ± 34mmHg (pb0.001). Majority of the
patients (81.8%) showed clinical improvement in New York Heart
Association class of 1.3 ± 1.0. There is significant improvement in
severity of mitral regurgitation and reduction in inter-ventricular
septum (IVS) thickness with p value 0.02, 0.04 respectively, without
any significant reduction in left ventricular function. The mean post-
procedure creatinine kinase (CK) was 1570.0 ± 1011.2 IU/L. level of
N1000 IU/L showed strong correlation with LVOT PG reduction.
Conclusions: TASH is a safe and effective procedure in achieving
persistent and significant immediate and long term reduction in
LVOT pressure gradient and patient symptoms, as well as improve-
ment in echocardiographic variables such as mitral regurgitation.
doi:10.1016/j.ijcard.2017.09.097
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Background: In recent years, patients presentingwith acute coronary
syndrome (ACS) are significantly younger. Most of the patients in our
local data from Sungai Buloh Hospital lack the traditional cardiovascular
risk factors.
Objective: Identify demographics, risk factors, biochemical re-
sults, and carotid intimal medial thickness (CIMT) of young ACS.
Materials & Methods: This was a prospective, single center study
carried out in Cardiovascular and Thoracic Center (CTC) of University
Technology MARA (UiTM) in Sungai Buloh from 1st November 2016
until 14th February 2017. All patients were below 40 years old. Consent
were taken, and subsequently patients underwent blood testing and
carotid ultrasound.
Results: There was a total of 20 young ACS patients recruited along
with 20 healthy control subjects. The mean age was 35.3(±3.6) and
29.9(±2.7) in the young ACS and control cohort. All subjects weremale,
except 7 women in the control cohort. In the young ACS, there were
70%(n=14) STEMI and 30%(n=6) NSTEMI. Young ACS waist
circumference(cm) and BMI were 101.3(±4.4) and 28.9(±2.9) respec-
tively. Meanwhile in the control cohort, the WC was 82.6(±11.5) and
BMIwas 24.5(±4.3). YoungACS cardiovascular risk assessment revealed
85%(n=17) smokers, 45%(n=9) hypertension, 25%(n=5) DM and
25%(n=5) dyslipidemia. Conversely, in the control cohort there were
20% (n=4) smokers. Young ACS biochemical markers showed mean
fasting glucose level of 6.8 mmol/l(±1.2), and serum creatinine 91.4
μmol/L (±9.0). Lipid profile revealed mean total cholesterol of 5.57
mmol/L(±1.2), trigliceride 2.05 mmol/L(±0.7), HDL 1.01 mmol/
L(±0.3), and LDL of 3.66 mmol/L(±1.0). Young ACS echocardiography
had LVEF of 46.9%(±9.6), TAPSE 1.9cm(±0.2) and RV S’ 10cm/s(±0.3).
Carotid intimal medial thickness (CIMT) of young ACS and healthy
control were 0.78mm (±0.3) and 0.48mm (±0.1) respectively, with p-
value b 0.005. Two young ACS had CIMT of 1.22mm and 1.25mm. All
young STEMI (n=14) underwent primary percutaneous coronary
intervention.
Conclusion: CIMT can be used as an additional score in cardiovas-
cular risk stratification for young Malaysian adults.
doi:10.1016/j.ijcard.2017.09.098
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